Allogene Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $226k | 81k | 2.80 |
| 2024-06-30 | $158k | 68k | 2.33 |
| 2024-03-31 | $247k | 55k | 4.47 |
| 2023-12-31 | $174k | 54k | 3.21 |
| 2023-09-30 | $536k | 169k | 3.17 |
| 2023-06-30 | $824k | 166k | 4.97 |
| 2022-12-31 | $34k | 5.3k | 6.29 |
| 2022-09-30 | $77k | 7.2k | 10.71 |
| 2022-06-30 | $79k | 7.0k | 11.32 |
| 2022-03-31 | $118k | 13k | 8.92 |
| 2021-12-31 | $564k | 39k | 14.49 |
| 2021-09-30 | $545k | 20k | 26.67 |
| 2021-06-30 | $288k | 11k | 26.67 |
| 2021-03-31 | $187k | 5.3k | 35.20 |
| 2020-12-31 | $894k | 35k | 25.55 |
| 2020-09-30 | $1.1M | 29k | 37.81 |
| 2020-06-30 | $856k | 20k | 41.90 |
| 2020-03-31 | $558k | 29k | 19.44 |
| 2019-12-31 | $778k | 30k | 25.97 |
| 2019-09-30 | $742k | 27k | 27.27 |
| 2019-06-30 | $669k | 25k | 26.86 |
| 2019-03-31 | $1.1M | 40k | 28.92 |
| 2018-12-31 | $939k | 35k | 26.91 |